Aethlon Medical (AEMD) Stock Price, News & Analysis

Company Overview

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Key Stats

• Today's Range: $1.75 to $2.00
• 50-Day Range: $1.76 to $3.33
• 52-Week Range: $1.75 to $8.44
• Volume: 66,445 shs
• Average Volume: 201,077 shs
• Market Capitalization: $3.54 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $56.00
• Consensus Rating: Buy

Aethlon Medical Stock Analysis - MarketRank™

Aethlon Medical scored higher than 62% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Aethlon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Aethlon Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Aethlon Medical are expected to grow in the coming year, from ($0.73) to ($0.49) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aethlon Medical is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aethlon Medical is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Aethlon Medical has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.08% of the float of Aethlon Medical has been sold short.

Short Interest Ratio / Days to Cover

Aethlon Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aethlon Medical has recently decreased by 86.34%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aethlon Medical does not currently pay a dividend.

Dividend Growth

Aethlon Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.08% of the float of Aethlon Medical has been sold short.

Short Interest Ratio / Days to Cover

Aethlon Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aethlon Medical has recently decreased by 86.34%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.48

News Sentiment

Aethlon Medical has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Aethlon Medical this week, compared to 1 article on an average week.

Search Interest

3 people have searched for AEMD on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aethlon Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.20% of the stock of Aethlon Medical is held by insiders.

Percentage Held by Institutions

Only 1.99% of the stock of Aethlon Medical is held by institutions.

AEMD Stock Analysis - Frequently Asked Questions

How have AEMD shares performed this year?

Aethlon Medical's stock was trading at $6.88 at the beginning of the year. Since then, AEMD shares have decreased by 74.4% and is now trading at $1.76.
View the best growth stocks for 2025 here.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings data on Wednesday, February, 12th. The medical equipment provider reported ($1.04) EPS for the quarter, beating analysts' consensus estimates of ($1.76) by $0.72.
Read the conference call transcript.

When did Aethlon Medical's stock split?

Shares of Aethlon Medical reverse split before market open on Thursday, October 5th 2023. The 1-10 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Aethlon Medical's major shareholders?

Top institutional investors of Aethlon Medical include Armistice Capital LLC (8.89%).
View institutional ownership trends.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aethlon Medical investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), NVIDIA (NVDA), Pfizer (PFE), Plug Power (PLUG), Vaxart (VXRT) and Organigram (OGI).

Company Calendar

• Last Earnings: 2/12/2025
• Today: 6/14/2025
• Next Earnings (Estimated): 6/26/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AEMD
• CIK: 773910
• Web: www.aethlonmedical.com
• Phone: (858) 459-7800
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $56.00
• High Stock Price Target: $56.00
• Low Stock Price Target: $56.00
• Potential Upside/Downside: +3,081.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($12.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$12.21 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -153.96%
• Return on Assets: -109.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.80
• Quick Ratio: 2.80

Sales & Book Value

• Annual Sales: $570 thousand
• Price / Sales: 6.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.19 per share
• Price / Book: 0.80

Miscellaneous

• Outstanding Shares: 2,011,000
• Free Float: 14,298,000
• Market Cap: $3.54 million
• Optionable: No Data
• Beta: 1.89